127 related articles for article (PubMed ID: 17939045)
1. Determination of body fat distribution by dual-energy X-ray absorptiometry and attenuation of visceral fat vasoconstriction by enalapril.
Leung FW; Murray S; Murray E; Go VL
Dig Dis Sci; 2008 Apr; 53(4):1084-7. PubMed ID: 17939045
[TBL] [Abstract][Full Text] [Related]
2. Capsaicin-sensitive intestinal mucosal afferent mechanism and body fat distribution.
Leung FW
Life Sci; 2008 Jul; 83(1-2):1-5. PubMed ID: 18541272
[TBL] [Abstract][Full Text] [Related]
3. Pilot studies to demonstrate that intestinal mucosal afferent nerves are functionally linked to visceral adipose tissue.
Leung FW; Go VL; Scremin OU; Obenaus A; Tuck ML; Golub MS; Eggena P; Leung JW
Dig Dis Sci; 2007 Oct; 52(10):2695-702. PubMed ID: 17393331
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
5. Changes in Body Fat Distribution on Dual-Energy X-Ray Absorptiometry in Black South Africans Starting First-Line Antiretroviral Therapy.
Abrahams Z; Levitt N; Lesosky M; Maartens G; Dave J
AIDS Patient Care STDS; 2016 Oct; 30(10):455-462. PubMed ID: 27749108
[TBL] [Abstract][Full Text] [Related]
6. Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
Tokioka T; Shibasaki M; Fujimori A; Matsuda-Satoh Y; Uchida W; Inagaki O; Yanagisawa I
Biol Pharm Bull; 2000 Feb; 23(2):174-81. PubMed ID: 10706380
[TBL] [Abstract][Full Text] [Related]
7. [A new simple method for estimating trunk and visceral fat by bioelectrical impedance: comparison with magnetic resonance imaging and dual X-ray absorptiometry in Czech adolescents].
Zamrazilová H; Hlavatý P; Dusátková L; Sedlácková B; Hainerová IA; Kunesová M; Skoch A; Hájek M; Hainer V
Cas Lek Cesk; 2010; 149(9):417-22. PubMed ID: 21117324
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats.
Carter CS; Cesari M; Ambrosius WT; Hu N; Diz D; Oden S; Sonntag WE; Pahor M
J Gerontol A Biol Sci Med Sci; 2004 May; 59(5):416-23. PubMed ID: 15123750
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme.
Becari C; Teixeira FR; Oliveira EB; Salgado MC
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H565-70. PubMed ID: 21602471
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of candesartan and enalapril on augmented vasoconstrictive responses to endothelin-1 in coronary vessels of spontaneously hypertensive rats.
Miki S; Takeda K; Hatta T; Harada S; Kido H; Oguni A; Moriguchi J; Morimoto S; Kawa T; Sasaki S; Nakagawa M
Am J Hypertens; 2002 Mar; 15(3):286-90. PubMed ID: 11939622
[TBL] [Abstract][Full Text] [Related]
11. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
Dukacz SA; Kline RL
J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
[TBL] [Abstract][Full Text] [Related]
12. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
Münzel T; Bassenge E
Circulation; 1996 Jun; 93(11):2052-8. PubMed ID: 8640982
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
[TBL] [Abstract][Full Text] [Related]
14. Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats.
Mathai ML; Naik S; Sinclair AJ; Weisinger HS; Weisinger RS
Int J Obes (Lond); 2008 Oct; 32(10):1576-84. PubMed ID: 18698317
[TBL] [Abstract][Full Text] [Related]
15. Effect of enalapril and quinapril on forearm vascular ACE in man.
Lyons D; Webster J; Benjamin N
Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I
Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of renal blood flow of the outer and inner cortex by laser-Doppler flowmetry in anesthetized dogs: effect of enalapril diacid.
Noguchi K; Ojiri Y; Chibana T; Sakanashi M
Arch Int Pharmacodyn Ther; 1992; 320():68-80. PubMed ID: 1300943
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
[TBL] [Abstract][Full Text] [Related]
19. Visceral vasodilatation and somatic vasoconstriction evoked by acid challenge of the rat gastric mucosa: diversity of mechanisms.
Wachter C; Heinemann A; Jocic M; Holzer P
J Physiol; 1995 Jul; 486 ( Pt 2)(Pt 2):505-16. PubMed ID: 7473214
[TBL] [Abstract][Full Text] [Related]
20. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
